Comparative Sequence and Structural Analyses of G-Protein-Coupled Receptor Crystal Structures and Implications for Molecular Models

Background Up until recently the only available experimental (high resolution) structure of a G-protein-coupled receptor (GPCR) was that of bovine rhodopsin. In the past few years the determination of GPCR structures has accelerated with three new receptors, as well as squid rhodopsin, being successfully crystallized. All share a common molecular architecture of seven transmembrane helices and can therefore serve as templates for building molecular models of homologous GPCRs. However, despite the common general architecture of these structures key differences do exist between them. The choice of which experimental GPCR structure(s) to use for building a comparative model of a particular GPCR is unclear and without detailed structural and sequence analyses, could be arbitrary. The aim of this study is therefore to perform a systematic and detailed analysis of sequence-structure relationships of known GPCR structures. Methodology We analyzed in detail conserved and unique sequence motifs and structural features in experimentally-determined GPCR structures. Deeper insight into specific and important structural features of GPCRs as well as valuable information for template selection has been gained. Using key features a workflow has been formulated for identifying the most appropriate template(s) for building homology models of GPCRs of unknown structure. This workflow was applied to a set of 14 human family A GPCRs suggesting for each the most appropriate template(s) for building a comparative molecular model. Conclusions The available crystal structures represent only a subset of all possible structural variation in family A GPCRs. Some GPCRs have structural features that are distributed over different crystal structures or which are not present in the templates suggesting that homology models should be built using multiple templates. This study provides a systematic analysis of GPCR crystal structures and a consistent method for identifying suitable templates for GPCR homology modelling that will help to produce more reliable three-dimensional models.

[1]  E. Zrenner,et al.  Three novel rhodopsin mutations (C110F, L131P, A164V) in patients with autosomal dominant retinitis pigmentosa. , 1994, Human molecular genetics.

[2]  A. Goede,et al.  Loops In Proteins (LIP)--a comprehensive loop database for homology modelling. , 2003, Protein engineering.

[3]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[4]  R. Paschke,et al.  Contacts between Extracellular Loop Two and Transmembrane Helix Six Determine Basal Activity of the Thyroid-stimulating Hormone Receptor* , 2007, Journal of Biological Chemistry.

[5]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[6]  H. Weinstein,et al.  Structural mimicry of proline kinks: tertiary packing interactions support local structural distortions. , 2002, Journal of molecular biology.

[7]  D. Oprian,et al.  Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness , 1994, Nature.

[8]  B. Raaka,et al.  Understanding the structural and functional differences between mouse thyrotropin‐releasing hormone receptors 1 and 2 , 2008, Proteins.

[9]  M. Wheatley,et al.  The third extracellular loop of G-protein-coupled receptors: more than just a linker between two important transmembrane helices. , 2004, Biochemical Society transactions.

[10]  D. Bichet,et al.  Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus , 1992, Nature.

[11]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[12]  K. Clément,et al.  Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  Stefano Costanzi,et al.  On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. , 2008, Journal of medicinal chemistry.

[14]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[15]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[16]  Marie Chabbert,et al.  An Indel in Transmembrane Helix 2 Helps to Trace the Molecular Evolution of Class A G-Protein-Coupled Receptors , 2009, Journal of Molecular Evolution.

[17]  Andreas Hildebrandt,et al.  Revisiting automated G-protein coupled receptor modeling: the benefit of additional template structures for a neurokinin-1 receptor model. , 2009, Journal of medicinal chemistry.

[18]  Jan Freudenberg,et al.  Cannabinoid receptor type 2 gene is associated with human osteoporosis. , 2005, Human molecular genetics.

[19]  M. Burghammer,et al.  Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.

[20]  Krzysztof Palczewski,et al.  Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.

[21]  S. Tunaru,et al.  Characterization of Determinants of Ligand Binding to the Nicotinic Acid Receptor GPR109A (HM74A/PUMA-G) , 2005, Molecular Pharmacology.

[22]  Raymond C Stevens,et al.  Discovery of new GPCR biology: one receptor structure at a time. , 2009, Structure.

[23]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[24]  J. Stockman.  Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease , 2010 .

[25]  G. Krause,et al.  Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor. , 2000, Molecular pharmacology.

[26]  S Henikoff,et al.  Performance evaluation of amino acid substitution matrices , 1993, Proteins.

[27]  S. A. Hassan,et al.  Key issues in the computational simulation of GPCR function: representation of loop domains , 2002, J. Comput. Aided Mol. Des..

[28]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[29]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[30]  Manfred Burghammer,et al.  Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.

[31]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[32]  J. Jan,et al.  Acquired ocular visual impairment in children. 1960-1989. , 1993, American journal of diseases of children.

[33]  H. Guy,et al.  Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.

[34]  R. Koup,et al.  Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7. , 2001, Virology.

[35]  H Weinstein,et al.  Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.

[36]  W. Delano.  The PyMOL Molecular Graphics System (2002) , 2002 .

[37]  Viktor Hornak,et al.  Helix Movement is Coupled to Displacement of the Second Extracellular Loop in Rhodopsin Activation , 2009, Nature Structural &Molecular Biology.

[38]  D. Clark Robert,et al.  Ligand- and Structure-Based Virtual Screening , 2010 .

[39]  Krzysztof Palczewski,et al.  Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors , 2009, Proceedings of the National Academy of Sciences.

[40]  T. Schöneberg,et al.  Mutationally Induced Disulfide Bond Formation within the Third Extracellular Loop Causes Melanocortin 4 Receptor Inactivation in Patients with Obesity* , 2003, Journal of Biological Chemistry.

[41]  Tsutomu Kouyama,et al.  Crystal structure of squid rhodopsin , 2008, Nature.

[42]  G. Krause,et al.  Structural determinants for selective recognition of peptide ligands for endothelin receptor subtypes ETA and ETB , 2009, Journal of peptide science : an official publication of the European Peptide Society.

[43]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[44]  H. Schiöth,et al.  The Repertoire of G-Protein–Coupled Receptors in Fully Sequenced Genomes , 2005, Molecular Pharmacology.

[45]  U. Leser,et al.  Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. , 2007, Molecular endocrinology.

[46]  S. Filetti,et al.  Activating mutations of the TSH receptor in differentiated thyroid carcinomas. , 1995, Oncogene.

[47]  B. Dean,et al.  Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2002, Molecular Psychiatry.

[48]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[49]  Gert Vriend,et al.  GRIS: glycoprotein-hormone receptor information system. , 2006, Molecular endocrinology.

[50]  Gerhard Hessler,et al.  Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.

[51]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[52]  G Vriend,et al.  Heavier‐than‐air flying machines are impossible , 2004, FEBS letters.

[53]  Charles L. Brooks,et al.  Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 , 2009, Nature Reviews Drug Discovery.

[54]  K. Clément,et al.  Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.

[55]  Katrin Sangkuhl,et al.  Mutant G-protein-coupled receptors as a cause of human diseases. , 2004, Pharmacology & therapeutics.

[56]  R. Seyer,et al.  Structure of the third intracellular loop of the vasopressin V2 receptor and conformational changes upon binding to gC1qR. , 2009, Journal of molecular biology.

[57]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2000, Science.

[58]  R. Paschke,et al.  Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor – a basally active GPCR , 2008, Cellular and Molecular Life Sciences.

[59]  D. Oprian,et al.  Constitutively active mutants of rhodopsin , 1992, Neuron.

[60]  Duan Yang,et al.  The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Schott.  Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice , 2010 .

[62]  E. Jönsson,et al.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: Evidence from fixed‐ and random‐effects meta‐analyses , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[63]  Manfred Burghammer,et al.  Crystal structure of a thermally stable rhodopsin mutant. , 2007, Journal of molecular biology.

[64]  David Julius,et al.  Identification of the platelet ADP receptor targeted by antithrombotic drugs , 2001, Nature.

[65]  R. Adan,et al.  Poor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity* , 2003, Journal of Biological Chemistry.

[66]  A. Meyer-Lindenberg,et al.  Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans , 2009, Molecular Psychiatry.

[67]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.

[68]  Q. Gu,et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.

[69]  Ron O Dror,et al.  Identification of two distinct inactive conformations of the β2-adrenergic receptor reconciles structural and biochemical observations , 2009, Proceedings of the National Academy of Sciences.

[70]  Baldomero Oliva,et al.  A supersecondary structure library and search algorithm for modeling loops in protein structures , 2006, Nucleic acids research.

[71]  J. Hebebrand,et al.  A Heterozygous Mutation in the Third Transmembrane Domain Causes a Dominant-Negative Effect on Signalling Capability of the MC4R , 2008, Obesity Facts.

[72]  D. Tregouet,et al.  Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. , 2007, The Journal of clinical endocrinology and metabolism.

[73]  Tetsuya Hori,et al.  Crystal Structure of Squid Rhodopsin with Intracellularly Extended Cytoplasmic Region , 2008, Journal of Biological Chemistry.

[74]  K. Palczewski,et al.  Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.

[75]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[76]  William C. Olson,et al.  Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry , 1998, Journal of Virology.

[77]  R. Seifert,et al.  Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins. , 2000, Molecular pharmacology.

[78]  A. D. McLachlan,et al.  Rapid comparison of protein structures , 1982 .

[79]  Cathy H. Wu,et al.  The Universal Protein Resource (UniProt) , 2004, Nucleic Acids Res..

[80]  D. Doyle,et al.  Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. , 1999, The New England journal of medicine.

[81]  A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. , 2003 .

[82]  Nagarajan Vaidehi,et al.  Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. , 2008, Journal of molecular biology.

[83]  N. Samani,et al.  Dimorphism in the P2Y1 ADP Receptor Gene Is Associated With Increased Platelet Activation Response to ADP , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[84]  Charlotte M. Deane,et al.  JOY: protein sequence-structure representation and analysis , 1998, Bioinform..

[85]  H. Attrill,et al.  Improved yield of a ligand-binding GPCR expressed in E. coli for structural studies. , 2009, Protein expression and purification.

[86]  Shuguang Zhang,et al.  High-Level Production, Solubilization and Purification of Synthetic Human GPCR Chemokine Receptors CCR5, CCR3, CXCR4 and CX3CR1 , 2009, PloS one.

[87]  R. Pierson,et al.  Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. , 2003, The New England journal of medicine.